Breaking News Instant updates and real-time market news.

ABC

AmerisourceBergen

$88.95

-4.05 (-4.35%)

, MCK

McKesson

$142.22

-5.4 (-3.66%)

15:03
03/20/18
03/20
15:03
03/20/18
15:03

Drug distribution stocks fall ahead of federal action on opioids, Bloomberg says

Anticipating U.S. government action against drug companies tied to the opioid crisis, investors are selling drug distribution companies, says Bloomberg. Companies in the medical distribution space include AmerisourceBergen (ABC), McKesson (MCK), Cardinal Health (CAH) and Henry Schein (HSIC). Reference Link

ABC

AmerisourceBergen

$88.95

-4.05 (-4.35%)

MCK

McKesson

$142.22

-5.4 (-3.66%)

CAH

Cardinal Health

$65.80

-4.19 (-5.99%)

HSIC

Henry Schein

$67.83

-0.22 (-0.32%)

  • 12

    Jun

ABC AmerisourceBergen
$88.95

-4.05 (-4.35%)

02/27/18
BOFA
02/27/18
INITIATION
Target $111
BOFA
Buy
AmerisourceBergen reinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Michael Cherny reinstated coverage on AmerisourceBergen with a Buy and $111 price target.
02/27/18
COWN
02/27/18
NO CHANGE
Target $108
COWN
Outperform
AmerisourceBergen selloff on CNBC report brings buying opportunity, says Cowen
The selloff in shares of AmerisourceBergen (ABC) after CNBC reported that discussions with Walgreens Boots Alliance (WBA) regarding a merger have ended with no agreement presents a buying opportunity, Cowen analyst Charles Rhyee tells investors in an intraday research note. AmerisourceBergen is down 5%, or $4.98, to $95.60 in afternoon trading. The company's underlying fundamentals "remain on solid footing" and current valuation levels "still look compelling," Rhyee contends. The analyst keeps an Outperform rating on AmerisourceBergen with a $108 price target.
03/05/18
ARGS
03/05/18
NO CHANGE
Target $115
ARGS
Buy
AmerisourceBergen price target raised to $115 from $100 at Argus
Argus analysts David Toung and Marisa Janeczek raised their price target on AmerisourceBergen (ABC) to $115, saying the company's Q1 earnings were marked by "solid results in pharma distribution, specialty distribution, and consulting and logistics services". The analysts keeps their Buy rating on the stock, adding that despite the termination of merger talks with Walgreen Boots (WBA), there are strong growth opportunities for the stock as the company begins operations at six new distribution centers. Toung and Janeczek note that the 7% pullback in the stock price marks a favorable entry point.
03/08/18
LEHM
03/08/18
INITIATION
Target $104
LEHM
Equal Weight
AmerisourceBergen initiated with an Equal Weight at Barclays
Barclays analyst Steve Valiquette started AmerisourceBergen with an Equal Weight rating and $104 price target. The analyst initiated 14 companies in Health Care Services with a Neutral industry view.
MCK McKesson
$142.22

-5.4 (-3.66%)

02/14/18
JEFF
02/14/18
NO CHANGE
JEFF
Amazon focusing on bolstering medical device distribution, says Jefferies
Yesterday's Wall Street Journal report and a recent scan of job postings still point to Amazon.com's (AMZN) focus on bolstering its medical device/supplies distribution capabilities, specifically targeting hospitals, Jefferies analyst Brian Tanquilut. These postings support a negative thesis for Cardinal Health (CAH), Owens & Minor (OMI) and Premier's (PINC) medical supplies businesses, the analyst adds. Further, he sees the news as an incremental positive for AmerisourceBergen (ABC), McKesson (MCK), CVS Health (CVS) and Walgreens Boots Alliance (WBA) since it further supports the view that Amazon isn't looking to enter the prescription business near-term.
03/08/18
LEHM
03/08/18
INITIATION
Target $165
LEHM
Equal Weight
McKesson initiated with an Equal Weight at Barclays
Barclays analyst Steve Valiquette started McKesson with an Equal Weight rating and $165 price target. The analyst initiated 14 companies in Health Care Services with a Neutral industry view.
02/27/18
BOFA
02/27/18
INITIATION
Target $179
BOFA
McKesson reinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Michael Cherny reinstated coverage on McKesson with a Buy and $179 price target.
02/27/18
BOFA
02/27/18
INITIATION
Target $179
BOFA
Buy
McKesson reinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Michael Cherny reinstated coverage on McKesson with a Buy and $179 price target.
CAH Cardinal Health
$65.80

-4.19 (-5.99%)

03/08/18
LEHM
03/08/18
INITIATION
Target $74
LEHM
Equal Weight
Cardinal Health initiated with an Equal Weight at Barclays
Barclays analyst Steve Valiquette started Cardinal Health with an Equal Weight rating and $74 price target. The analyst initiated 14 companies in Health Care Services with a Neutral industry view.
02/27/18
BOFA
02/27/18
INITIATION
Target $69
BOFA
Underperform
Cardinal Health reinstated with an Underperform at BofA/Merrill
BofA/Merrill analyst Michael Cherny reinstated coverage on Cardinal Health with an Underperform and $69 price target.
01/04/18
EVER
01/04/18
INITIATION
Target $67
EVER
In Line
Cardinal Health initiated with an In Line at Evercore ISI
Evercore ISI started Cardinal Health with an In Line rating and $67 price target.
HSIC Henry Schein
$67.83

-0.22 (-0.32%)

03/02/18
MSCO
03/02/18
NO CHANGE
Target $20
MSCO
Underweight
Hard to call bottom for Patterson Companies shares, says Morgan Stanley
Morgan Stanley analyst Steve Beuchaw said Patterson Companies' (PDCO) continued share losses and market deterioration make the right multiple "unknowable" and calling the bottom for the stock challenging. His end market tracking and field checks continued to skew negative in recent months, but then Henry Schein's (HSIC) results suggested he was too cautious. However, Patterson's report shows that Henry Schein's execution and DSO positioning obscured an environment that does look tougher overall in Q4, said Beuchaw. He keeps an Underweight rating on Patterson and lowered his price target on the stock to $20 from $31.
03/08/18
LEHM
03/08/18
INITIATION
Target $71
LEHM
Equal Weight
Henry Schein initiated with an Equal Weight at Barclays
Barclays analyst Steve Valiquette started Henry Schein with an Equal Weight rating and $71 price target. The analyst initiated 14 companies in Health Care Services with a Neutral industry view.
03/09/18
BARD
03/09/18
NO CHANGE
Target $81
BARD
Outperform
Henry Schein weakness a buying opportunity, says Baird
Baird analyst Jeff Johnson noted investors have concerns about current overhangs at Henry Schein, but he believes the shares are oversold at current levels. He considers any FTC risk as negligible and has increased confidence in management's ability to sustain its 4-5% organic revenue growth. Johnson reiterated his Outperform rating and $81 price target on Henry Schein shares.
02/27/18
BOFA
02/27/18
INITIATION
Target $76
BOFA
Neutral
Henry Schein reinstated with a Neutral at BofA/Merrill
BofA/Merrill analyst Michael Cherny reinstated coverage on Henry Schein with a Neutral and $76 price target.

TODAY'S FREE FLY STORIES

WYNN

Wynn Resorts

$189.70

-3.54 (-1.83%)

08:33
04/25/18
04/25
08:33
04/25/18
08:33
Recommendations
Wynn Resorts analyst commentary  »

Wynn Resorts price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

BDGE

Bridge Bancorp

$32.75

0.3 (0.92%)

08:33
04/25/18
04/25
08:33
04/25/18
08:33
Earnings
Bridge Bancorp reports Q1 EPS 61c, consensus 59c »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

ORBC

ORBCOMM

$9.07

-0.18 (-1.95%)

08:33
04/25/18
04/25
08:33
04/25/18
08:33
Hot Stocks
ORBCOMM, Maerospace extend AIS contract with government of Canada »

ORBCOMM announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 29

    May

ABBV

AbbVie

$91.34

-1.8 (-1.93%)

08:33
04/25/18
04/25
08:33
04/25/18
08:33
Hot Stocks
AbbVie reports upadacitinib meets primary endpoints in Phase 2b/3 RA study »

AbbVie announced results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 27

    Apr

  • 08

    May

  • 21

    May

  • 05

    Jun

DIN

Dine Brands

$73.96

-0.13 (-0.18%)

08:33
04/25/18
04/25
08:33
04/25/18
08:33
Recommendations
Dine Brands analyst commentary  »

Dine Brands price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

CERS

Cerus

$5.38

-0.09 (-1.65%)

08:32
04/25/18
04/25
08:32
04/25/18
08:32
Hot Stocks
Cerus announces Health Canada approval of Intercept blood system for platelets »

Cerus Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

GSAT

Globalstar

$0.73

-0.0513 (-6.58%)

, CTL

CenturyLink

$17.95

0.225 (1.27%)

08:31
04/25/18
04/25
08:31
04/25/18
08:31
Hot Stocks
Globalstar to merge with FiberLight, acquire other assets in stock transaction »

Globalstar (GSAT)…

GSAT

Globalstar

$0.73

-0.0513 (-6.58%)

CTL

CenturyLink

$17.95

0.225 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

  • 22

    May

CMCSA

Comcast

$33.34

-0.52 (-1.54%)

08:31
04/25/18
04/25
08:31
04/25/18
08:31
Technical Analysis
Technical Take: Comcast at new 52-week low after results »

At the current price of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

ABBV

AbbVie

$91.34

-1.8 (-1.93%)

08:31
04/25/18
04/25
08:31
04/25/18
08:31
Hot Stocks
Breaking Hot Stocks news story on AbbVie »

AbbVie reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 27

    Apr

  • 08

    May

  • 21

    May

  • 05

    Jun

FE

FirstEnergy

$34.30

-0.2 (-0.58%)

08:31
04/25/18
04/25
08:31
04/25/18
08:31
Hot Stocks
FirstEnergy Solutions files to deactive three nuclear power plants »

FirstEnergy's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

AMZN

Amazon.com

$1,460.08

-56.99 (-3.76%)

08:31
04/25/18
04/25
08:31
04/25/18
08:31
Periodicals
Amazon to launch Fire TV Cube, could have Alexa built in, CNBC says »

Amazon has confirmed Fire…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

BUFF

Blue Buffalo Pet Products

$40.00

0.035 (0.09%)

, WLB

Westmoreland

08:30
04/25/18
04/25
08:30
04/25/18
08:30
Options
One new option listing and two option delistings on April 25th »

New option listings for…

BUFF

Blue Buffalo Pet Products

$40.00

0.035 (0.09%)

WLB

Westmoreland

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NAV

Navistar

$36.28

-1.64 (-4.32%)

, VLKAY

Volkswagen

08:30
04/25/18
04/25
08:30
04/25/18
08:30
Recommendations
Navistar, Volkswagen analyst commentary  »

VW acquisition scenario…

NAV

Navistar

$36.28

-1.64 (-4.32%)

VLKAY

Volkswagen

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$93.08

-2.25 (-2.36%)

08:29
04/25/18
04/25
08:29
04/25/18
08:29
Conference/Events
House Appropriations Committee to hold a hearing »

The Labor, Health &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

TWTR

Twitter

$30.48

-0.74 (-2.37%)

08:28
04/25/18
04/25
08:28
04/25/18
08:28
Hot Stocks
Breaking Hot Stocks news story on Twitter »

Dorsey says Twitter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    May

KPTI

Karyopharm

$13.62

-0.43 (-3.06%)

08:26
04/25/18
04/25
08:26
04/25/18
08:26
Recommendations
Karyopharm analyst commentary  »

Karyopharm shares could…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLS

Sellas Life Sciences

$5.01

0.07 (1.42%)

08:25
04/25/18
04/25
08:25
04/25/18
08:25
Conference/Events
Sellas Life Sciences to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 08

    May

ACN

Accenture

$151.02

-2.07 (-1.35%)

08:25
04/25/18
04/25
08:25
04/25/18
08:25
Conference/Events
Accenture to host analyst and investor meeting »

Analyst and Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

NTES

NetEase

$254.24

-6.44 (-2.47%)

08:24
04/25/18
04/25
08:24
04/25/18
08:24
Upgrade
NetEase rating change  »

NetEase upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMNY

Helios and Matheson

$2.41

-0.04 (-1.63%)

08:23
04/25/18
04/25
08:23
04/25/18
08:23
Initiation
Helios and Matheson initiated  »

Helios and Matheson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJT

DJ Transportation Average

08:20
04/25/18
04/25
08:20
04/25/18
08:20
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

08:20
04/25/18
04/25
08:20
04/25/18
08:20
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$30.48

-0.74 (-2.37%)

08:20
04/25/18
04/25
08:20
04/25/18
08:20
Hot Stocks
Twitter says removed more than 142K apps violating TOS in Q1 »

In its Q1 letter to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    May

CR

Crane

$87.78

-7.56 (-7.93%)

08:20
04/25/18
04/25
08:20
04/25/18
08:20
Upgrade
Crane rating change  »

Crane upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

GE

General Electric

$14.68

0.16 (1.10%)

08:20
04/25/18
04/25
08:20
04/25/18
08:20
Hot Stocks
General Electric, U.S. Army conduct PDR for T901 engine »

GE Aviation hosted the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.